Results 91 to 100 of about 1,960,485 (306)
ABSTRACT Objectives The association between exposure to dinutuximab beta (DB) and event‐free survival (EFS) or overall survival (OS) of neuroblastoma patients was assessed using data collected during three clinical trials (five cohorts). Methods A systematic review (March 2026) was conducted to identify relevant studies (prospective; registered DB ...
Przemysław Holko +19 more
wiley +1 more source
In the red zone (Inside Story) [PDF]
Australian journalist Martin Chulov tells Peter Clarke about the challenges of reporting from Iraq and the preparations for January's election.
Martin Chulov, Peter Clarke
core
Introduction The efficacy and safety of Ivabradine for patients with acute heart failure (AHF) is controversial, and there are few clinical trials addressing this topic.
Jing Han +3 more
doaj +1 more source
ABSTRACT Results of COG ANBL1221 changed treatment paradigms for patients with relapsed/refractory neuroblastoma. Chemoimmunotherapy with irinotecan/temozolomide/dinutuximab is now used as both bridge therapy following suboptimal response to induction and as treatment in first relapse.
Elizabeth Sokol +6 more
wiley +1 more source
Enterococcus alishanensis JNUCC 77 (=BLH10) was isolated from the flowers of Zinnia elegans collected at Ilchul Land, Jeju Island, Republic of Korea.
Kyung-A Hyun +3 more
doaj +1 more source
ABSTRACT Background Medication nonadherence during the first 100 days after pediatric hematopoietic stem cell transplantation (HSCT) and during oncology treatment increases risk for complications. BMT4me is a caregiver‐facing mobile health (mHealth) application providing medication reminders, symptom tracking, and note‐taking features to support ...
Micah A. Skeens +4 more
wiley +1 more source
'It's good to be back' (Inside Story) [PDF]
Barack Obama has gone onto the front foot, but did he leave it too late? Political historian David Farber discusses the post healthcare reform prospects with Peter Clarke.
David Farber, Peter Clarke
core
In Vitro and In Silico Studies of Maculosin as a Melanogenesis and Tyrosinase Inhibitor
The investigation of melanogenesis and tyrosinase inhibitors is essential for developing safe and effective natural compounds to treat pigmentation disorders.
Yang Xu +3 more
doaj +1 more source

